Adalimumab Biosimilar Market: Emerging Trends, Key Drivers, and Future Growth Prospects
The Adalimumab Biosimilar Market is developing rapidly as pharmaceutical companies expand their biosimilar portfolios and healthcare systems seek opportunities to reduce treatment costs. The market was valued at USD 4.9 billion in 2025 and is forecast to reach USD 15.0 billion by 2035 at an estimated CAGR of 11.8%. By indication, the market includes rheumatoid arthritis, Crohn's disease,...
0 Комментарии 0 Поделились 116 Просмотры 0 предпросмотр